Determining the accuracy of blood pressure measurement by the Omron HEM-907 before and after hemodialysis

Blood Pressure Monitoring
Marek CzarkowskiJoanna Matuszkiewicz-Rowińska

Abstract

The accuracy of oscillometric blood pressure (BP) measuring devices determined in resting conditions may be distorted in those under hemodialysis (HD). The evaluation of accuracy of the Omron HEM-907 was performed in accordance with the International Protocol for validation of BP measuring devices (IP). Out of a group of 49 patients with end-stage renal disease (ESRD) (56.7 +/- 15.6 years), four groups of 33 patients each were selected to ascertain their BP before and after HD. The Omron HEM-907 fulfilled the IP accuracy requirements for systolic BP measurements before and after HD. In the case of diastolic BP before HD, the Omron HEM-907 did not fulfill both requirements for phase 2.2 IP. In only 21 out of 33 patients, the difference between the mean of two observers and the Omron HEM-907 device (Diff) was not more than 5 mmHg, while the requirement was 22 patients. In seven patients, all three Diff were over 5 mmHg, while the accepted limit is three. After HD, the Omron HEM-907 did not fulfill one out of two criteria of phase 2.2 IP - in five people, all three Diff were over 5 mmHg. The Omron HEM-907 oscillometric method of BP measurement should not be used to measure BP before and after HD in ESRD patients. In ESRD patients,...Continue Reading

References

Oct 31, 2000·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·A J PeixotoW B White
Jun 1, 2002·Blood Pressure Monitoring·Eoin O'BrienUNKNOWN Working Group on Blood Pressure Monitoring of the European Society of Hypertension
Aug 29, 2002·Blood Pressure Monitoring·Mohamed A El AssaadRoland G Asmar
Feb 27, 2003·Blood Pressure Monitoring·Thomas G Pickering
Apr 26, 2003·Journal of Hypertension·Eoin O'BrienUNKNOWN European Society of Hypertension Working Group on Blood Pressure Monitoring
Feb 7, 2004·Blood Pressure·Marek CzarkowskiKrzysztof Rózanowski
Mar 17, 2004·Blood Pressure Monitoring·Marek CzarkowskiKrzysztof Rózanowski
Mar 24, 2004·Journal of Human Hypertension·M CzarkowskiK Rózanowski
Apr 10, 2004·Current Opinion in Nephrology and Hypertension·Gianfranco ParatiGiuseppe Mancia
Jun 25, 2004·Advances in Chronic Kidney Disease·Niranjan SankaranarayananAldo J Peixoto
Jul 15, 2004·Seminars in Dialysis·Andrew E LazarMahboob Rahman
Mar 19, 2005·Journal of Hypertension·Eoin O'BrienUNKNOWN European Society of Hypertension Working Group on Blood Pressure Monitoring
Jan 18, 2008·Clinical Journal of the American Society of Nephrology : CJASN·Hidekazu MoriyaShuzo Kobayashi

❮ Previous
Next ❯

Citations

Jul 4, 2012·International Urology and Nephrology·Tekin AkpolatKenan Ateş
Mar 31, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Rajiv Agarwal
Apr 2, 2011·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Marek CzarkowskiStanislaw Niemczyk
Jun 19, 2012·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Matthew A RobertsUNKNOWN Beta-Blocker to Lower Cardiovascular Dialysis Events (BLOCADE) Feasibility Study Trial Management Committee
Feb 6, 2014·Seminars in Dialysis·Tariq ShafiPhilip G Zager
Aug 24, 2016·American Journal of Hypertension·Martin G Myers
Apr 6, 2019·Current Hypertension Reports·Romsai T BoonyasaiJoseph E Landavaso

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.